162849-96-9 Usage
Uses
Used in Pharmaceutical Industry:
ETHYL 2-AMINOTHIAZOLE-5-CARBOXYLATE HYDROCHLORIDE is used as a chemical intermediate for the synthesis of various therapeutic compounds, contributing to the development of new drugs and pharmaceutical ingredients.
Used in Anticancer Applications:
In the field of oncology, ETHYL 2-AMINOTHIAZOLE-5-CARBOXYLATE HYDROCHLORIDE is utilized for its anticancer properties, potentially aiding in the development of treatments for various types of cancer.
Used in Antifungal Applications:
ETHYL 2-AMINOTHIAZOLE-5-CARBOXYLATE HYDROCHLORIDE is employed for its antifungal properties, which can be instrumental in creating medications to combat fungal infections.
Used in Drug Development and Research:
This chemical compound is used in drug development and research to explore its diverse biological activities and potential therapeutic applications, furthering the understanding of its role in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 162849-96-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,8,4 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 162849-96:
(8*1)+(7*6)+(6*2)+(5*8)+(4*4)+(3*9)+(2*9)+(1*6)=169
169 % 10 = 9
So 162849-96-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O2S.ClH/c1-2-10-5(9)4-3-8-6(7)11-4;/h3H,2H2,1H3,(H2,7,8);1H
162849-96-9Relevant academic research and scientific papers
Pharmaceutical composition for inhibiting HIV protease
-
, (2008/06/13)
A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a mixture of (1) (a) a solvent selected from propylene glycol and polyethylene glycol or (b) a solvent selected from polyoxyethyleneglycerol triricinoleate, polyethylene glycol 40 hydrogenated castor oil, fractionated coconut oil, polyoxyethylene (20) sorbitan monooleate and 2-(2-ethoxyethoxy)ethanol or (c) a mixture thereof and (2) ethanol or propylene glycol.
Pharmaceutical composition
-
, (2008/06/13)
A solid pharmaceutical composition is disclosed which comprises a pharmaceutically acceptable adsorbent or a mixture of pharmaceutically acceptable adsorbents to which is adsorbed a mixture of (1) a pharmaceutically acceptable organic solvent or a mixture of pharmaceutically acceptable organic solvents, (2) an HIV protease inhibiting compound and (3) one or more pharmaceutically acceptable acids. The solid composition can optionally be encapsulated in a hard gelatin capsule.
